Chlorpromazine versus lithium for people with schizophrenia
| dc.contributor.author | Tyrrell, Katie | |
| dc.contributor.author | Mancias Guerra, Claudia | |
| dc.contributor.author | Rikhraj, Shareen | |
| dc.date.accessioned | 2017-09-29T13:10:14Z | |
| dc.date.available | 2017-09-29T13:10:14Z | |
| dc.date.issued | 2017 | |
| dc.identifier.citation | Cardoso, D., Tyrrell, K., Mancias Guerra, C. & Rikhraj, S. (2017). Chlorpromazine versus lithium for people with schizophrenia. Cochrane Database of Systematic Reviews, 2017 (7), pp.1-13. | |
| dc.identifier.other | 10.1002/14651858.CD012737 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12904/9993 | |
| dc.description.abstract | This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To investigate the effects of chlorpromazine alone versus lithium alone in the treatment of schizophrenia, schizophrenia-like psychoses and schizoaffective psychoses. It is expected that the implementation of several subgroup analyses may be possible (see Subgroup analysis and investigation of heterogeneity). © 2017 The Cochrane Collaboration. Published by JohnWiley & Sons, Ltd. | |
| dc.description.uri | http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD012737/full | |
| dc.format | Full text uploaded | |
| dc.subject | Drug therapy | |
| dc.subject | Schizophrenia | |
| dc.title | Chlorpromazine versus lithium for people with schizophrenia | |
| dc.type | Article | |
| refterms.dateFOA | 2021-06-14T11:08:23Z | |
| html.description.abstract | This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To investigate the effects of chlorpromazine alone versus lithium alone in the treatment of schizophrenia, schizophrenia-like psychoses and schizoaffective psychoses. It is expected that the implementation of several subgroup analyses may be possible (see Subgroup analysis and investigation of heterogeneity). © 2017 The Cochrane Collaboration. Published by JohnWiley & Sons, Ltd. |
